Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading 0.2% Higher – Here’s What Happened

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) shot up 0.2% during trading on Tuesday . The stock traded as high as $10.77 and last traded at $10.76. Approximately 156,232 shares traded hands during trading, an increase of 424% from the average daily volume of 29,796 shares. The stock had previously closed at $10.74.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a research note on Tuesday, June 30th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Stock Up 0.2%

The business has a fifty day simple moving average of $10.71 and a 200 day simple moving average of $10.67.

Institutional Investors Weigh In On Oaktree Acquisition Corp. III Life Sciences

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Rangeley Capital LLC raised its holdings in Oaktree Acquisition Corp. III Life Sciences by 52.8% in the 1st quarter. Rangeley Capital LLC now owns 61,188 shares of the company’s stock valued at $647,000 after buying an additional 21,156 shares during the last quarter. DLD Asset Management LP grew its stake in shares of Oaktree Acquisition Corp. III Life Sciences by 0.9% in the first quarter. DLD Asset Management LP now owns 136,735 shares of the company’s stock worth $1,447,000 after purchasing an additional 1,200 shares during the last quarter. Lineage Point Capital LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth $2,461,000. Empyrean Capital Partners LP increased its holdings in Oaktree Acquisition Corp. III Life Sciences by 20.0% in the fourth quarter. Empyrean Capital Partners LP now owns 900,000 shares of the company’s stock valued at $9,522,000 after purchasing an additional 150,000 shares during the period. Finally, Radcliffe Capital Management L.P. raised its position in Oaktree Acquisition Corp. III Life Sciences by 67.1% during the 4th quarter. Radcliffe Capital Management L.P. now owns 377,065 shares of the company’s stock worth $3,989,000 after purchasing an additional 151,403 shares during the last quarter.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.